Pardeep Nijhawan Provides Update to Beneficial Ownership of Securities of Edesa Biotech, Inc.

MARKHAM, Ontario, Sept. 13, 2024 (GLOBE NEWSWIRE) -- Dr. Pardeep Nijhawan ("Dr. Nijhawan") announces that as a result of grants of restricted share units ("RSUs") of Edesa Biotech, Inc. ("Edesa"), when combined with a series of transactions (the "Transactions") that have occurred since the date of the most recent early warning report filed by Dr. Nijhawan on November 18, 2022 (the "Previous Report"), Dr. Nijhawan has acquired "beneficial ownership" of common shares in the capital of Edesa ("Common Shares") ...